1. In May 2017, the Seventieth World Health Assembly, having considered the report on the public health dimension of the world drug problem,1 adopted decision WHA70(18),2 in which it requested the Director-General to continue efforts to improve the coordination and collaboration of WHO with UNODC and the International Narcotics Control Board, within their existing mandates, and to report on the implementation of the decision to the Seventy-first, Seventy-third and Seventy-fifth World Health Assemblies, and to continue to keep the Commission on Narcotic Drugs appropriately informed of relevant programmes and progress. In May 2021, the Seventy-fourth World Health Assembly adopted decision WHA74(17)3 in the context of the WHO governance reform process, in which it decided, inter alia, that future reporting on governing bodies mandates should receive greater specificity.

2. In resolution S-30/1, the United Nations General Assembly adopted the outcome document of its 2016 special session on the world drug problem, which included operational recommendations to effectively address and counter the world drug problem, in some of which WHO was explicitly mentioned.

Action by the health assembly:
15. The Health Assembly is invited to note the report and to consider the following draft decision:
The Seventy-fifth World Health Assembly, having considered the report of the Director-General, Decided to request the Director-General to continue to report to the Health Assembly every two years until 2030 on WHO’s activities to address the public health dimensions of the world drug problem and progress made in the implementation of decision WHA70(18) (2017).